MedRhythms, Inc.

Are you interested in training in Neurologic Music Therapy (NMT)?? The Academy of Neurologic Music Therapy will be holding an NMT Training hosted by MedRhythms at the Spaulding Rehabilitation Hospital in Boston, Massachusetts from April 24-27th! ?? The Academy of Neurologic Music Therapy? will teach a 4-day, 30-hour workshop providing allied professionals, music therapists, and students with the clinical training and scientific knowledge necessary to practice within the Neurologic Music Therapy? (NMT?) System of Techniques. Pretraining- 5 hours Synchronous-31.5 Speech Track- 18.5 hours Cognitive Track-18.25 hours Sensorimotor Track-18.5 hours Allied Professionals are able to register for the tracks that are most relevant for them. Music therapists must complete the entirety of the training to become an Neurologic Music Therapist. This event will be held in person and there will be a registration option for those who are interested in participating online.

MedRhythms today announced that MR-005, the company's neurorehabilitation system to support gait rehabilitation and motor function in adults with Parkinson's disease (PD), has been listed as a Class II, Rx-only medical device with the U.S. Food and Drug Administration (FDA). The company unveiled the system's brand name: Movive?. #parkinsonsdisease #rhythmicauditorystimulation https://lnkd.in/gwtPrY5y

MedRhythms and its scientific collaborators are advancing rhythmic auditory stimulation (RAS) for walking rehabilitation, particularly in chronic neurodegeneration and injury. At AAP’s #Physiatry25 Brian Harris will present a poster showing that InTandem? is designed for safe and effective independent use by adult chronic stroke patients. InTandem is a home-use medical device intended to improve walking that delivers personalized, progressive RAS through music. #physiatry #chronicstroke

"As a student in music therapy at the University of Maine, Brian Harris became intrigued with the ability of rhythm and music to change the brain." Continue reading the article in Forbes published this February to learn more about the origins of MedRhythms. You'll hear how rhythmic auditory stimulation, a form of neurologic music therapy, creates a profound response for patients, and how it was built into MedRhythms products like InTandem.

?? Exciting Opportunity for Neurologic Music Therapists! ?? MedRhythms Therapy is now offering professional supervision to enhance your clinical expertise and elevate your practice. Join our expert team to: ?? Elevate care standards ?? Gain skills for effective NMT interventions ?? Collaborate to make a meaningful difference Ready to get started? Complete an intake form today! ?? ?? Visit our website https://lnkd.in/gk_AHdNi ?? Contact: [email protected] #NeurologicMusicTherapy #ProfessionalDevelopment #MEDRhythmsTherapy

Join our new group, "Harmonizing Speech and Communication," designed by skilled Neurologic Music Therapists (NMTs) and Speech-Language Pathologists (SLPs). We use music to enhance communication skills in individuals with cognitive-communication difficulties. Music creates a supportive, stimulating environment for language development. Experience the power of music in overcoming barriers and building connections! Drop-in, monthly, and full program rates available. For more info, contact: SLPAmyKaras.com

MedRhythms today announced that Joel Behnke has been hired as Chief Commercial Officer. Mr. Behnke brings over two decades of commercial leadership in medical devices to MedRhythms where he will drive sales and marketing efforts across the pipeline of products, with initial focus on commercialization of InTandem, the company's flagship neurorehabilitation system for chronic stroke gait impairment.

MedRhythms today announced that InTandem?, the company's flagship rehabilitation system for chronic stroke gait impairment, received a final payment determination from the Centers for Medicare and Medicaid Services (CMS). CMS finalized the preliminary pricing determination that payments would be made on a capped rental basis, with monthly Medicare payment amounts based on the commercial pricing for InTandem.

MedRhythms today announced that CMS established a new HCPCS code to describe InTandem: E3200 (gait modulation system, rhythmic auditory stimulation, including restricted therapy software, all components and accessories, prescription only). CMS also determined that InTandem qualified under Medicare’s durable medical equipment (DME) benefit category based on InTandem’s durability and indication for home use. Learn more in the press release:

We invite you to join us for a free introduction to NMT and MedRhythms Therapy's student programs! Click the link to reserve your spot: